PDT Partners LLC acquired a new stake in Natera, Inc. (NASDAQ:NTRA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 57,900 shares of the medical research company’s stock, valued at approximately $629,000. PDT Partners LLC owned about 0.11% of Natera at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of NTRA. Teachers Advisors LLC lifted its stake in Natera by 5.0% in the 4th quarter. Teachers Advisors LLC now owns 44,224 shares of the medical research company’s stock valued at $518,000 after purchasing an additional 2,116 shares during the last quarter. Nationwide Fund Advisors lifted its stake in Natera by 7.3% in the 1st quarter. Nationwide Fund Advisors now owns 62,273 shares of the medical research company’s stock valued at $552,000 after purchasing an additional 4,246 shares during the last quarter. Prudential Financial Inc. lifted its stake in Natera by 185.9% in the 1st quarter. Prudential Financial Inc. now owns 73,820 shares of the medical research company’s stock valued at $654,000 after purchasing an additional 48,000 shares during the last quarter. American International Group Inc. lifted its stake in Natera by 7.1% in the 1st quarter. American International Group Inc. now owns 16,065 shares of the medical research company’s stock valued at $142,000 after purchasing an additional 1,068 shares during the last quarter. Finally, Alliancebernstein L.P. lifted its stake in Natera by 5.6% in the 1st quarter. Alliancebernstein L.P. now owns 26,600 shares of the medical research company’s stock valued at $236,000 after purchasing an additional 1,400 shares during the last quarter. 59.79% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://www.watchlistnews.com/57900-shares-in-natera-inc-ntra-purchased-by-pdt-partners-llc/1615293.html.

In other news, insider Jonathan Sheena sold 120,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $12.54, for a total value of $1,504,800.00. Following the completion of the sale, the insider now directly owns 533,208 shares in the company, valued at approximately $6,686,428.32. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 12.57% of the company’s stock.

NTRA has been the subject of several research reports. Zacks Investment Research downgraded shares of Natera from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. ValuEngine downgraded shares of Natera from a “sell” rating to a “strong sell” rating in a research note on Monday, July 24th. BidaskClub downgraded shares of Natera from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. Morgan Stanley dropped their price objective on shares of Natera from $18.00 to $13.00 and set an “overweight” rating for the company in a research note on Monday, August 7th. Finally, Cowen and Company reissued a “buy” rating and issued a $14.00 price objective on shares of Natera in a research note on Friday, September 1st. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $15.05.

Natera, Inc. (NASDAQ:NTRA) opened at 14.31 on Friday. The company’s market cap is $761.62 million. The company has a 50-day moving average of $13.02 and a 200 day moving average of $13.02. Natera, Inc. has a 52 week low of $7.88 and a 52 week high of $14.76.

Natera (NASDAQ:NTRA) last announced its quarterly earnings data on Tuesday, August 8th. The medical research company reported ($0.52) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.52). The firm had revenue of $53.60 million during the quarter, compared to analyst estimates of $50.57 million. Natera had a negative net margin of 62.64% and a negative return on equity of 137.46%. The business’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the business posted ($0.46) EPS. On average, equities analysts forecast that Natera, Inc. will post ($2.03) EPS for the current fiscal year.

Natera Company Profile

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.